3P3-19812-47445
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 442 / OH
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-06
- 2021-04-08
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-29
- 2021-05-06
-
2021-05-13
Survey response — day 21, dose 2MedDRA: Erythema, Hypersensitivity, Rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Red bumpy rash on lower legs started a week ago. After consultation with dermatology they believe a hypersensitive reaction to covid vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-21
- 2021-06-03
- 2021-06-07
- 2021-07-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-13 | Unsuccessful 2021-06-07 |
Free text
Release 8 — day 21, dose 2
Symptoms: Red bumpy rash on lower legs started a week ago. After consultation with dermatology they believe a hypersensitive reaction to covid vaccine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release